| Structure | Chemical Name | CAS | MF |
|
3-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-ylcarbonyl}piperidine
|
|
|
|
3-oxatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione
|
|
C12H6O3
|
|
|
4-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}butanoic acid
|
|
|
|
4-Oxatricyclo[6.2.0.03,5]decane (9CI)
|
343264-77-7
|
C9H14O
|
|
|
4-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}-4-oxobutanoic acid
|
|
|
|
|
1-{5-oxatricyclo[7.4.0.0^{2,6}]trideca-1,3,6,8,10,12-hexaen-4-yl}ethan-1-one
|
|
|
|
|
1-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}hexan-1-amine
|
|
|
|
|
1-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}propan-1-amine
|
|
|
|
1-OXA-4,10,16-TRITHIA-7,13-DIAZACYCLOOCTADECANE
|
343372-28-1
|
C12H26N2OS3
|
|
3-oxatricyclo[3.2.1.02,4]octane
|
278-74-0
|
C7H10O
|
|
|
11-OXA-TRICYCLO[6.2.1.0*2,7*]UNDECA-2,4,6,9-TETRAENE
|
|
|
|
2,2'-[1-OXA-4,10,16-TRITHIA-7,13-DIAZACYCLOOCTADECANE-7,13-DIYLBIS(METHYLENE)]BIS-8-QUINOLINOL
|
343372-33-8
|
C32H40N4O3S3
|
|
|
3-oxa-4,5,6-trinor-3,7-inter-3-phenyleneprostaglandin E1 amide
|
|
|
|
3-Oxatricyclo[3.2.1.02,4]octane-6,7-dicarboxylicacid,(1R,5S,6S,7R)-rel-(9CI)
|
669695-26-5
|
C9H10O5
|
|
3-Oxa-1,7,8-triazaspiro[4.4]nonane(9CI)
|
126505-39-3
|
C5H11N3O
|
|
3-Oxatricyclo[3.2.1.02,4]octane,6-ethoxy-(9CI)
|
373358-46-4
|
C9H14O2
|
|
11-Oxa-2,6,9-triazatridecanoic acid, 12,12-dimethyl-5,10-dioxo-, phenylmethyl ester (9CI)
|
651354-72-2
|
C18H27N3O5
|
|
4-oxatricyclo[5.2.1.0~2,6~]dec-8-ene-3,5-dione
|
|
C9H8O3
|
|
3-oxatricyclo[5.2.2.0~1,5~]undec-8-en-4-one
|
|
C10H12O2
|
|
1-Oxa-4,7,10-triazacyclododecane-4,7,10-trisacetic acid
|
112193-74-5
|
C14H25N3O7
|
|
2-Oxatricyclo[20.2.2.13,7]heptacosa-3,5,7(27),22,24(1),25-hexene-5,24,25-triol triacetate
|
27825-38-3
|
C32H42O7
|
|
12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-13,13-dimethyl-3 -[[4-[3-(4-morpholinyl)propoxy]phenyl]methyl]-11-oxo-9-(phenylmethyl)- , 1,1-dimethylethyl ester, [3S-(3R*,4S*,8S*,9R*)]-
|
162539-73-3
|
C37H58N4O8
|
|
12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-13,13-dimethyl-1 1-oxo-3-[[4-[2-(2-oxo-3-oxazolidinyl)ethoxy]phenyl]methyl]-9-(phenylme thyl)-, 1,1-dimethylethyl ester, [3S-(3R*,4S*,8S*,9R*)]-
|
162540-90-1
|
C35H52N4O9
|
|
4-Oxatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5-dione, 10,10-dimethyl-7-(trim ethylsilyl)-
|
|
C14H20O3Si
|
|
7-Oxatricyclo(4.3.0.03,9)nonan-4-one, 1-(beta-D-glucopyranosyloxy)-9-( hydroxymethyl)-8-methoxy-6-methyl-
|
84808-29-7
|
|
|
3-Oxatricyclo[5.2.1.02,4]decane (9CI)
|
475437-08-2
|
C9H14O
|
|
1,2,3,4-Oxatriazol-5(2H)-one
|
172957-05-0
|
CHN3O2
|
|
3-Oxatricyclo[3.2.1.02,4]octan-6-ol, [1S-(1-alpha-,2-bta-,4-bta-,5-alpha-,6-alpha-)]- (9CI)
|
132617-02-8
|
C7H10O2
|
|
1,2,3,4-Oxatriazol-5-amine, N,N-dimethyl-
|
71082-04-7
|
C3H6N4O
|
|
3-Oxatricyclo[4.2.0.02,4]oct-7-ene
|
176020-70-5
|
C7H8O
|
|
4-Oxatricyclo[5.2.1.03,5]decane (9CI)
|
166377-87-3
|
C9H14O
|
|
1,2,3,4-Oxatriazole, 5-[(tribromomethyl)sulfonyl]-
|
263557-13-7
|
C2Br3N3O3S
|
|
1,2,3,4-Oxatriazol-5-amine, conjugate monoacid (9CI)
|
194469-82-4
|
CH3N4O+
|
|
3-Oxatricyclo[3.2.1.02,4]octane, 6-ethyl- (9CI)
|
132945-25-6
|
C9H14O
|
|
3-Oxatricyclo[5.2.0.02,4]nonan-8-one
|
|
C8H10O2
|
|
3-Oxatricyclo[4.2.1.02,5]non-7-ene,4,4-difluoro-(9CI)
|
658074-45-4
|
C8H8F2O
|
|
3-Oxatricyclo[3.2.1.02,4]octane,6-nitro-,(1-alpha-,2-bta-,4-bta-,5-alpha-,6-bta-)-(9CI)
|
107969-31-3
|
C7H9NO3
|
|
1-Oxa-4,6,9-triazaspiro[4.4]nonane(9CI)
|
340702-13-8
|
C5H11N3O
|
|
9-Oxatricyclo[4.2.1.12,5]decan-10-one,3-ethyl-2,5-dimethyl-,(1R,2R,3R,5S,6S)-rel-(9CI)
|
578714-71-3
|
C13H20O2
|
|
3-Oxatricyclo[3.2.1.02,4]octan-6-amine(9CI)
|
220555-36-2
|
C7H11NO
|
|
3-Oxatricyclo[3.2.1.02,4]octane-6-methanamine,N,N-diethyl-,(1-alpha-,2-bta-,4-bta-,5-alpha-,6-alpha-)-(9CI)
|
50991-32-7
|
C12H21NO
|
|
4-Oxatricyclo[5.1.0.03,5]octan-1-ol,5-(1-methylethyl)-(9CI)
|
218786-63-1
|
C10H16O2
|
|
3-Oxatricyclo[3.2.1.02,4]octane-6-carboxylicacid,[1R-(1alpha,2beta,4beta,5alpha,6alpha)]-(9CI)
|
135357-67-4
|
C8H10O3
|
|
1-Oxa-4,7,8-triazaspiro[4.4]nonane(9CI)
|
767323-97-7
|
C5H11N3O
|
|
9-Oxatricyclo[4.2.1.12,5]decan-10-one,3-ethyl-2,5-dimethyl-,(1R,2R,3S,5S,6S)-rel-(9CI)
|
578714-86-0
|
C13H20O2
|
|
|
1-{8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl}ethan-1-amine
|
|
|
|
3-Oxatricyclo[3.2.1.02,4]octane-6-carboxaldehyde (9CI)
|
132945-26-7
|
C8H10O2
|
|
|
8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl(pyridin-4-yl)methanamine
|
|
|
|
|
8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-amine
|
|
|
|
|
8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl(phenyl)methanamine
|
|
|
|
3-Oxatricyclo[2.2.1.02,6]heptane-1-carboxylicacid,5-hydroxy-,methylester(9CI)
|
90687-25-5
|
C8H10O4
|
|
9-Oxa-1,3,5-triazaspiro[5.5]undecane(9CI)
|
353799-74-3
|
C7H15N3O
|
|
3-Oxatricyclo[5.1.0.02,4]oct-5-ene,8-(1-methylethyl)-,(1alpha,2bta,4bta,7alpha,8alpha)-(9CI)
|
76778-82-0
|
C10H14O
|
|
3-Oxatricyclo[3.2.1.02,4]octan-6-ol,acetate(9CI)
|
78987-90-3
|
C9H12O3
|
|
8-Oxatricyclo[3.2.1.02,4]octane,3,3-difluoro-,(1R,2S,4R,5S)-rel-(9CI)
|
277755-62-1
|
C7H8F2O
|
|
3-Oxatricyclo[2.2.1.02,6]heptane-1-carboxylicacid,5-hydroxy-,methylester,stereoisomer(9CI)
|
90762-16-6
|
C8H10O4
|
|
3-Oxatricyclo[4.1.0.02,4]heptane,2-methyl-6-(1-methylethyl)-,[1S-(1alpha,2bta,4bta,6alpha)]-(9CI)
|
174512-63-1
|
C10H16O
|
|
oxaunomycin
|
105615-58-5
|
C26H29NO10
|
|
Oxcarbazepine N--D-Glucuronide
|
1260595-39-8
|
C21H20N2O8
|
|
Oxcarbazepine N-Sulfate
|
1159977-54-4
|
C15H12N2O5S
|
|
Oxcarbazepine Enol-sulfate
|
104746-00-1
|
C15H12N2O5S
|
|
|
Oxcarbazepine Related Compound A (10 mg) (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
|
|
|
|
Oxcarbazepine-D4 (Major)
|
1020719-71-4
|
C15H12N2O2
|
|
|
Oxcarbazepine Glucuronide
|
|
C21H20N2O8
|
|
|
Oxcarbazepine-d10
|
|
C15H2N2O2D10
|
|
|
Oxcarbazepine-d2
|
|
C15H10N2O2D2
|
|
3-OXAURACIL
|
34314-63-1
|
C4H3NO3
|
|
OXCARBAZEPINE-D4
|
1134188-71-8
|
C15H8D4N2O2
|
|
Oxcarbazepine
|
28721-07-5
|
C15H12N2O2
|
|
|
OxcarbazepineAnticonvulsants
|
|
|
|
|
Oxcarbazepin
|
|
|
|
Oxcarbazepine D-Glucuronide
|
|
C21H20N2O8
|
|
24-oxavitamin D3
|
|
C26H42O2
|
|
|
OWL MICROFUGE RACK
|
|
|
|
|
OWL MODEL B1A UVT GEL TRAY
|
|
|
|
|
OWL MODEL S1S EARED GLASS PLATE 20 X 45CM
|
|
|
|
|
OWL MODEL B2 CASTING CHAMBER FOR 3 GELS
|
|
|
|
|
OWL MODEL B1 COMB - 10 TOOTH 1.5 mm
|
|
|
|
|
OWL MODEL P1 - BLANK GLASS PLATE 16CM WIDE X 14CM LONG, 1/8'' THICK
|
|
|
|
|
OWL MODEL P2 COMB, 25 TOOTH, 0.8MMTHICK OWL PART 1 P2-25C
|
|
|
|
|
OWL MODEL S4S COMPLETE SYSTEM ALUMINUM BACKED SEQUENCER 20CM W X 50CM H
|
|
|
|
|
OWL MODEL B1 DNA RNA MINIGEL SYSTEM
|
|
|
|
|
OWL MODEL P2X COMPLETE SYSTEM OWL PART 1 P2X
|
|
|
|
|
OWL MODEL S1S BLANK GLASS PLATE 20 X 45CM
|
|
|
|
|
OWL MODEL MP-REPLACEMENT PVC CLAMPS
|
|
|
|
|
OWL MODEL S3S - BLANK GLASS PLATE 35CM WIDE X 45CM LONG, 3/16'' THICK
|
|
|
|
|
OWL MODEL S1S SEQUENCER 20CM WIDE X 45CM LONG
|
|
|
|
|
OWL MODEL B2 UVT GEL TRAY
|
|
|
|
|
OWL MODEL MP - REPLACEMENT GASKET
|
|
|
|
|
OWL MODEL P1 - EARED GLASS PLATE 16CM WIDE X 14CM LONG, 1/8'' THICK
|
|
|
|
|
OWL MODEL B1A OR B2 ''OWLSEYE'' BUBBLE LEVEL
|
|
|
|
|
OWL MODEL S1S SHARKTOOTH COMB 39 TOOTH, 0.4MM THICK OWL PART 1 S1S-SHARK4
|
|
|
|
|
OWL MODEL S3S - GEL FIXING TANK 16'' WIDE X 19'' LONG X 1.5'' HIGH
|
|
|
|
|
OWL MODEL P1 - REPLACEMENT GASKET
|
|
|
|
|
OWL MODEL P1 - OFFSET GLASS PLATE 16CM WIDE X 12CM LONG, 1/8'' THICK
|
|
|
|
|
OWL MODEL P2 NOTCHED GLASS PLATE OWL PART 1 P2-20R
|
|
|
|
|
OWL MODEL A2-BP A2 MODEL WITH SPECIAL BUFFER PORTS USE MODEL A2 ACCESSORIES
|
|
|
|
|
OWL MODEL S1S SHARKTOOTH COMB, MICROTITER FORMAT, 55 TOOTH, 0.4MM THICK 1S1S-MT3
|
|
|
|
|
OWL MODEL S3S - OFFSET GLASS PLATE35CM WIDE X 43CM LONG, 3/16'' THICK
|
|
|
|
|
OWL MODEL P2 SPACER SET 1.0CM W X 0.8MM THICK OWL PART 1 P2-SC
|
|
|